ALKS Form 10-Q: Quarterly report

Alkermes plc. Form 10-Q: Quarterly report

Filings on SEC EDGAR, newest first; amendments sit with their base form. Values are as filed.

2026-07-28: Form 10-Q; Period of report 2026-06-30; Description 10-Q; Document alks-20260630.htm.
2026-05-05: Form 10-Q; Period of report 2026-03-31; Description 10-Q; Document alks-20260331.htm.
2025-10-28: Form 10-Q; Period of report 2025-09-30; Description 10-Q; Document alks-20250930.htm.
2025-07-29: Form 10-Q; Period of report 2025-06-30; Description 10-Q; Document alks-20250630.htm.

Filed	Form	Period of report	Description	Document
2026-07-28	10-Q	2026-06-30	10-Q	alks-20260630.htm
2026-05-05	10-Q	2026-03-31	10-Q	alks-20260331.htm
2025-10-28	10-Q	2025-09-30	10-Q	alks-20250930.htm
2025-07-29	10-Q	2025-06-30	10-Q	alks-20250630.htm
2025-05-01	10-Q	2025-03-31	10-Q	alks-20250331.htm
2024-10-24	10-Q	2024-09-30	10-Q	alks-20240930.htm
2024-07-24	10-Q	2024-06-30	10-Q	alks-20240630.htm
2024-05-01	10-Q	2024-03-31	10-Q	alks-20240331.htm
2023-10-25	10-Q	2023-09-30	10-Q	alks-20230930.htm
2023-07-26	10-Q	2023-06-30	10-Q	alks-20230630.htm
2023-04-26	10-Q	2023-03-31	10-Q	alks-10q_20230331.htm
2022-11-02	10-Q	2022-09-30	10-Q	alks-20220930.htm
2022-07-27	10-Q	2022-06-30	10-Q	alks-10q_20220630.htm
2022-04-27	10-Q	2022-03-31	10-Q	alks-10q_20220331.htm
2021-10-27	10-Q	2021-09-30	10-Q	alks-10q_20210930.htm
2021-07-28	10-Q	2021-06-30	10-Q	alks-10q_20210630.htm
2021-04-28	10-Q	2021-03-31	10-Q	alks-10q_20210331.htm
2020-10-29	10-Q	2020-09-30	10-Q	alks-10q_20200930.htm
2020-07-29	10-Q	2020-06-30	10-Q	alks-10q_20200630.htm
2020-04-29	10-Q	2020-03-31	10-Q	alks-10q_20200331.htm
2019-10-23	10-Q	2019-09-30	10-Q	alks-10q_20190930.htm
2019-07-25	10-Q	2019-06-30	10-Q	alks-10q_20190630.htm
2019-04-25	10-Q	2019-03-31	2019 Q1 10-Q	alks-10q_20190331.htm
2018-10-23	10-Q	2018-09-30	10-Q	alks-10q_20180930.htm
2018-07-26	10-Q	2018-06-30	10-Q	alks-20180630x10q.htm
2018-04-26	10-Q	2018-03-31	10-Q	alks-20180331x10q.htm
2017-10-26	10-Q	2017-09-30	10-Q	alks-20170930x10q.htm
2017-07-27	10-Q	2017-06-30	10-Q	alks-20170630x10q.htm
2017-04-27	10-Q	2017-03-31	10-Q	alks-20170331x10q.htm
2016-11-02	10-Q	2016-09-30	10-Q	alks-20160930x10q.htm
2016-07-28	10-Q	2016-06-30	10-Q	alks-20160630x10q.htm
2016-04-28	10-Q	2016-03-31	10-Q	alks-20160331x10q.htm
2015-10-29	10-Q	2015-09-30	10-Q	alks-20150930x10q.htm
2015-07-30	10-Q	2015-06-30	10-Q	alks-20150630x10q.htm
2015-04-30	10-Q	2015-03-31	10-Q	alks-20150331x10q.htm
2014-10-29	10-Q	2014-09-30	10-Q	a14-19628_110q.htm
2014-07-31	10-Q	2014-06-30	10-Q	a14-13873_110q.htm
2014-04-30	10-Q	2014-03-31	10-Q	a14-8308_110q.htm
2013-10-31	10-Q	2013-09-30	10-Q	a13-19836_110q.htm
2013-07-25	10-Q	2013-06-30	10-Q	a13-15189_110q.htm
2013-01-31	10-Q	2012-12-31	10-Q	a12-28459_110q.htm
2012-11-01	10-Q	2012-09-30	10-Q	a12-19035_110q.htm
2012-07-26	10-Q	2012-06-30	10-Q	a12-12819_110q.htm
2012-02-02	10-Q	2011-12-31	10-Q	a11-32244_110q.htm
2011-11-03	10-Q	2011-09-30	FORM 10-Q	b87794ae10vq.htm

Similar stocks

Stock Name	Country	Market Cap	PE Ratio
RHYTHM PHARMACEUTICALS, INC. (RYTM)	United States	$6.771B	-37.20
IONIS PHARMACEUTICALS INC (IONS)	United States	$7.277B	-23.25
Liquidia Corp (LQDA)	United States	$6.347B	51.23
Amneal Pharmaceuticals, Inc. (AMRX)		$6.326B	25.62
Spyre Therapeutics, Inc. (SYRE)	United States	$7.685B	-43.69
Structure Therapeutics Inc. (GPCR)	United States	$7.710B	-53.41
Praxis Precision Medicines, Inc. (PRAX)	United States	$7.884B	-27.60
Mirum Pharmaceuticals, Inc. (MIRM)	United States	$5.798B	-8.81
Travere Therapeutics, Inc. (TVTX)	United States	$5.712B	-123.10
Oruka Therapeutics, Inc. (ORKA)	United States	$5.663B	-43.76